An introduction to multidisciplinary recommendations for Wilson's disease comprehensive diagnosis and management: 2022 practice guidance from the American Association for the Study of Liver Diseases
10.3760/cma.j.cn501113-20221102-00535
- VernacularTitle:《美国肝病学会肝豆状核变性实践指南2022年版》肝豆状核变性多学科综合诊断和管理推荐意见简介
- Author:
Wei HOU
1
;
Sujun ZHENG
;
Zhongping DUAN
Author Information
1. 首都医科大学附属北京佑安医院肝病中心，北京 100069
- Keywords:
Hepatolenticular degeneration;
Diagnosis;
Therapy;
Guidance;
American Association for the Study of Liver Diseases
- From:
Chinese Journal of Hepatology
2022;30(11):1151-1153
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of Wilson's disease (WD) is global, with an estimated prevalence rate of 30 per million or higher. WD clinical manifestations can be liver disease, progressive neurologic deficits (non evident or even absent liver dysfunction), psychiatric disorders, or a combination of these. Children and younger patients are more likely to develop WD as an isolated liver disease than older patients. Symptoms are often vague and can appear at any age. To that end, in 2022, the American Association for the Study of Liver Diseases published the full version of the WD guidelines and recommendations developed by a panel of experts, providing a modern approach for WD diagnosis and management in an effort to assist clinicians in implementing the most recent diagnostic and management strategies.
